1.71
0.05 (3.01%)
| Previous Close | 1.66 |
| Volume | 8,241 |
| Price / Sales | 29.32 |
| Price / Book | 0.240 |
| 52 Weeks Range |
| Operating Margin (TTM) | -7,855.96% |
| Diluted EPS (TTM) | -11.50 |
| Quarterly Revenue Growth (YOY) | 87.80% |
| Total Debt/Equity (MRQ) | 47.32% |
| Current Ratio (MRQ) | 21.68 |
| Operating Cash Flow (TTM) | -5.54 M |
| Levered Free Cash Flow (TTM) | -3.35 M |
| Return on Assets (TTM) | -35.44% |
| Return on Equity (TTM) | -72.53% |
Market Trend
| Short Term | Medium Term | ||
| Industry | Health Information Services (US) | Mixed | Bearish |
| Health Information Services (Global) | Mixed | Bearish | |
| Stock | Aclarion, Inc. | Mixed | Bullish |
Similar Stocks
| Stock | Market Cap | DY | P/E (TTM) | P/B |
|---|---|---|---|---|
| ACON | - | - | - | 0.240 |
| STRM | 23 M | - | - | 2.10 |
| ICCT | 8 M | - | - | 8.91 |
| MGRX | - | - | - | 0.310 |
| HCAT | - | - | - | 1.18 |
| ZCMD | - | - | - | 0.010 |
AIStockmoo Score
| Value 35% | -0.4 |
| AI Insight info | NA |
| Relative Valuation info | NA |
| Financial Health info | -0.4 |
| Timing 35% | -0.5 |
| AI Technical info | NA |
| Technical Oscillators info | -2.5 |
| Technical Moving Averages info | 2.5 |
| Smart Money 30% | 0.0 |
| Analyst Consensus info | 0.0 |
| Insider Activity info | NA |
| News Mood info | NA |
| Environment | ×1.07 |
| Macro Environment info | -3.3 |
| Sector vs Market (6M) | +12.2% |
| Pillar Agreement | ×1.00 |
| Not in score | |
| Price Volatility info | 1.1 |
| Final Score | -0.34 |
Select this tab to load the latest available analysis.
|
Aclarion Inc is a healthcare technology company that leverages Magnetic Resonance Spectroscopy (MRS), proprietary signal processing techniques, biomarkers, and augmented intelligence algorithms to optimize clinical treatments. The Company is first addressing the chronic low back pain market with Nociscan. Through a cloud connection, Nociscan receives magnetic resonance spectroscopy (MRS) data from an MRI machine for each lumbar disc being evaluated. In the cloud, proprietary signal processing techniques extract and quantify chemical biomarkers demonstrated to be associated with disc pain. When used with other diagnostic tools, Nociscan provides critical insights into the location of a patient's low back pain, giving physicians clarity to optimize treatment strategies. |
|
| Sector | Healthcare |
| Industry | Health Information Services |
| Investment Style | Small Value |
| % Held by Institutions | 0.08% |
No data within this time range.
No data within this time range.
Portfolio
| Realized Profit | - |
| Unrealized Profit | - |
| Dividend Received 2026 | - |
| Total Profit | - |
| Avg. Return | - |
| Quantity (Buy) | - |
| Avg. Price (Buy) | - |
| Quantity (Sold) | - |
| Avg. Price (Sold) | - |